Hostname: page-component-89b8bd64d-5bvrz Total loading time: 0 Render date: 2026-05-09T07:35:03.700Z Has data issue: false hasContentIssue false

Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative

Published online by Cambridge University Press:  22 April 2013

Taran Paulsen Hellebust*
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway Department of Medical Physics, Oslo University Hospital, The Radium Hospital, Oslo, Norway Department of Physics, University of Oslo, Oslo, Norway
Ingrid Espe Heikkilä
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway
Gunilla Frykholm
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway
Sverre Levernes
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway Department of Medical Physics, Oslo University Hospital, The Radium Hospital, Oslo, Norway
Dag Clement Johannessen
Affiliation:
Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway
Hans Bjerke
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway
Hilde Olerud
Affiliation:
Section for Quality Development in Medical Applications, Norwegian Radiation Protection Authority, Østerås, Norway
*
Correspondence to: Taran Paulsen Hellebust, Norwegian Radiation Protection Authority, PO Box 55, 1332 Østerås, Norway. Tel: +47 67 16 25 63. E-mail: neil.madle@varian.com
Rights & Permissions [Opens in a new window]

Abstract

Background and purpose

In radiotherapy (RT), there are high requirements for quality assurance (QA) in all the steps of the process. Development of QA systems are demanding in terms of financial and human resources. A national QA programme (KVIST) has been established in Norway to facilitate implementation of QA activity on hospital level.

Method

The KVIST organisation comprises the KVIST team, the reference group (RG) and the working groups (WGs). The KVIST team is multidisciplinary and are employed in permanent positions. The RG acts as an advisory body for the KVIST team in defining and ranking the priority of projects. Relevant national QA projects are identified in collaboration with the RG, and WGs are established to carry out the various projects.

Result

Several national consensus documents have been prepared by the various WGs. Systems for incident handling and activity reporting have been established and clinical audits have been implemented in Norwegian RT. Guidelines for RT of various diagnoses have also been prepared in collaboration with National Cancer groups.

Conclusion

The KVIST programme has been very well acknowledged in the Norwegian RT community. It has succeeded in creating a positive attitude towards QA and improved the communication between centres and the various professions.

Information

Type
Original Articles
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - SA
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence . The written permission of Cambridge University Press must be obtained for commercial re-use.
Copyright
Copyright © Cambridge University Press 2013
Figure 0

Figure 1 Organisational structure of KVIST.Abbreviation: NRPA, Norwegian Radiation Protection Authority.

Figure 1

Table 1 Elements in the KVIST programme

Figure 2

Figure 2 Clinical target volume delineation in a rectum cancer case performed by nine observers from different radiotherapy departments in Norway.

Figure 3

Figure 3 Example of figures derived from radiotherapy activity reporting in Norway. The diagram shows the number of treatment plans performed with different methods in Norway from 2001 to 2010.

Figure 4

Figure 4 A screen dump from the treatment planning system (TPS) showing a computerised tomography (CT) slice (transversal view) of the geometry phantom simulating 25° couch rotation and 35° gantry rotation. Since the red lines will follow the geometry of the phantom, the quality assurance (QA) procedure indicates that the TPS generates the field correctly.